about
Feline injection-site sarcoma: past, present and future perspectivesA mouse model of pulmonary metastasis from spontaneous osteosarcoma monitored in vivo by Luciferase imaging.Bone invading NSCLC cells produce IL-7: mice model and human histologic data.Glottic and skull indices in canine brachycephalic airway obstructive syndrome.European consensus document on mast cell tumours in dogs and cats.Heat shock protein expression in canine osteosarcoma.met oncogene activation qualifies spontaneous canine osteosarcoma as a suitable pre-clinical model of human osteosarcoma.Clinical outcome of 42 dogs with scapular tumors treated by scapulectomy: a Veterinary Society of Surgical Oncology (VSSO) retrospective study (1995-2010).Expression of Ki67, BCL-2, and COX-2 in canine cutaneous mast cell tumors: association with grading and prognosis.Strengths and Weaknesses of Pre-Clinical Models for Human Melanoma Treatment: Dawn of Dogs' Revolution for Immunotherapy.Immunohistochemical Study of STAT3 Expression in Feline Injection-site FibrosarcomasCSPG4-Specific Immunity and Survival Prolongation in Dogs with Oral Malignant Melanoma Immunized with Human CSPG4 DNAChondroitin sulfate proteoglycan-4: A biomarker and a potential immunotherapeutic target for canine malignant melanomaMET oncogene aberrant expression in canine osteosarcomaMarginal excision of low-grade spindle cell sarcoma of canine extremities: 35 dogs (1996-2006)Adrenal myelolipoma in a dogProteasomes are not a target for doxorubicin in feline injection-site sarcomaNeoadjuvant chemoradiotherapy and surgery as treatment for oral maxillary squamous cell carcinoma in a dogEfficacy of systemic adjuvant therapies administered to dogs after excision of oral malignant melanomas: 151 cases (2001-2012)
P50
Q28283795-F9B60BDC-C465-4300-8A6B-4FBC3B1221C4Q33324404-0DCA5304-17CA-4F67-94E4-F76BB157BC7AQ33523405-AF4C81A0-0D7C-4A3A-9B54-E1686F7B720CQ37553197-4604C803-202C-4A47-AC75-4C7B7722BE80Q38033673-0620EA9D-BF24-466C-8DE2-7F23FDC73CA7Q39502763-EFBEB3A7-5C9B-45DE-B8C9-FE6C54807DEEQ39859049-ED67F0C2-F838-4422-943F-9725FA2243B0Q43638724-8E1DA9AC-4FAA-433C-BBB1-F71EE66D822BQ43670982-2CE262D8-0EB5-457E-AFC9-8A76C650617FQ52657766-D4344CA3-981D-45AC-AEB1-F91B6D7B8604Q57977863-D92DB548-6583-45D9-9E84-931783394966Q61822490-D5CC7688-5AE0-4C73-97DF-56F1DC378DDAQ61942371-AAB33840-B5E8-441C-8914-AB761869E670Q73803195-82F220C3-637B-477F-A5C6-62065DBBDB8AQ79794175-4DAF9CBA-C7BC-4D0A-BFA1-99D4597CD87AQ81489692-7D590F38-570D-4791-BA51-E8AD577DBCA3Q84125329-58D15A2F-CE42-4D58-9945-6464AB4B9928Q84455277-BDA9B81F-38EE-46C3-B023-5CBF43F4319AQ87470030-D44B8E38-40DB-4B8C-8B5A-216DDE6CEE71
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Paolo Buracco
@ast
Paolo Buracco
@en
Paolo Buracco
@es
Paolo Buracco
@nl
type
label
Paolo Buracco
@ast
Paolo Buracco
@en
Paolo Buracco
@es
Paolo Buracco
@nl
prefLabel
Paolo Buracco
@ast
Paolo Buracco
@en
Paolo Buracco
@es
Paolo Buracco
@nl
P106
P31
P496
0000-0002-0181-0887